Long Covid is an elusive target for Big Pharma

This is the second column in a three-part Heard on the Street series on the long Covid.

The pharmaceutical industry has been developing vaccines and treatments for Covid-19 at breakneck speed, saving millions of lives. Yet treatments for the post-viral disease known as long Covid, which afflicts millions, are far from developed.